Authors: DEARMOND B FRANCISCO CA LIN JS HUANG FY HALLADAY S BARTIZEK RD SKARE KL

Citation: B. Dearmond et al., SAFETY PROFILE OF OVER-THE-COUNTER NAPROXEN SODIUM, Clinical therapeutics, 17(4), 1995, pp. 587-601

Authors: DSOUZA RW ARKEN AH PERRY DG SKARE KL MITRA S

Citation: Rw. Dsouza et al., A MODEL FOR OPEN-LABEL USAGE STUDIES WITH OTC DRUGS PRIOR TO NDA APPROVAL, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 139-139

Authors: NELSON S BRAHIM J SKARE KL BARTIZEK RD SORRENTINO JV SCHRYER N

Citation: S. Nelson et al., COMPARISON OF NAPROXEN (N), NAPROXEN SODIUM (NS), IBUPROFEN (I) AND PLACEBO (P) FOLLOWING ORAL-SURGERY, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 127-127